ALKERMES | Resultat Før Skat



Pre Tax Profit Lave om Dato
AbbVie USD 4.81B 1.54B 2024-12
Acadia Pharmaceuticals USD 161.08M 122.28M 2024-12
ALKERMES USD 443.75M 333.52M 2024-12
Amgen USD 3.38B 111M 2024-12
Biogen USD 572.2M 118.5M 2024-12
BioMarin Pharmaceutical USD 169.64M 35.2M 2024-12
Bristol-Myers Squibb USD 4.26B 226M 2024-12
Eli Lilly USD 5.54B 3.83B 2024-12
Gilead Sciences USD 2.96B 112M 2024-12
Intra Cellular Therapies USD -17202000 8.75M 2024-12
Ionis Pharmaceuticals USD -107000000 37M 2024-12
J&J USD 5.42B 1.86B 2024-12
Merck USD 5.22B 114M 2024-12
Neurocrine Biosciences USD 162.6M 27.7M 2024-12
Otsuka Holdings JPY 79.84B 33.98B 2024-12
Pfizer USD 4.44B 2.36B 2024-12
Regeneron Pharmaceuticals USD 958.1M 534.9M 2024-12
Vertex Pharmaceuticals USD 1.32B 109.7M 2024-12



ALKERMES Resultat Før Skat - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2025.